Skip to content

Clinical trials

Phase 1/2 Melanoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 1/2 Country / region: China Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20161
20171
20182
20191
20202
20222
20237
20242
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14
Completed5
Unknown status5
Not yet recruiting3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Binhui Biopharmaceutical Co., Ltd.2
Essen Biotech2
Shenzhen Geno-Immune Medical Institute2
Akeso1
BeiGene1
Beijing Biotech1
Beijing Immunochina Medical Science & Technology Co., Ltd.1
Beijing Scitech-Mq Pharmaceuticals Limited1
Beijing Tide Pharmaceutical Co., Ltd1
BioNTech SE1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma30
Carcinoma, Non-Small-Cell Lung8
Carcinoma, Hepatocellular4
Neoplasms4
Ovarian Neoplasms4
Stomach Neoplasms4
Colorectal Neoplasms3
Endometrial Neoplasms3
Prostatic Neoplasms3
Breast Neoplasms2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.